77
Participants
Start Date
May 18, 2022
Primary Completion Date
August 5, 2025
Study Completion Date
July 31, 2027
Bevacizumab
"All participants will receive a single intravitreal injection of bevacizumab in one or both eyes following enrollment into the study. The injection/s should be given as soon as possible but no later than 2 days after the diagnosis of type 1 ROP meeting all of the inclusion criteria and none of the exclusion criteria.~Eyes meeting eligibility criteria will receive a single dose of 0.063 mg or 0.25mg bevacizumab provided by the pharmacy at the investigator's institution."
New York Presbyterian David H Koch Center, New York
UPMC Children's Eye Center of Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Virginia Pediatric Eye Center, Norfolk
Duke University Eye Center, Durham
Storm Eye Institute, Mt. Pleasant
The Emory Eye Center, Atlanta
UK Ophthalmology and Visual Sciences, The Eye Clinic, Lexington
Pediatric Ophthalmology Associates, Inc., Columbus
Cincinnati Children's Hospital, Cincinnati
Indiana University School of Medicine, Indianapolis
Riley Hospital for Children, Indianapolis
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U of Illinois at Chicago Eye and Ear Infirmary, Chicago
University of Chicago, Hyde Park
Arkansas Childrens Hospital/ University of Arkansas Medical Sciences, Little Rock
Texas Children's Hospital - Dept. Of Ophthalmology, Houston
University of Utah Moran Eye Center, Salt Lake City
Jules Stein Eye Institute at the University of California, Los Angeles, Los Angeles
Univ of California, Irvine- Gavin Herbert Eye Institute, Irvine
University of California San Francisco Department of Ophthalmology, San Francisco
University of California, Davis, Sacramento
Casey Eye Institute, Portland
Greater Baltimore Medical Center, Baltimore
Boston Children's Hospital, Boston
IWK Health Centre, Halifax
Lead Sponsor
Pediatric Eye Disease Investigator Group
NETWORK
National Eye Institute (NEI)
NIH
Jaeb Center for Health Research
OTHER